Back
ProShares Ultra Nasdaq Biotechnology Vs. Fundamental Global Industry Stock Comparison
Sell
46
BIB
ProShares Ultra Nasdaq Biotechnology
Last Price:
59.65
Seasonality Move:
10.34%
Buy
62
FGF
Fundamental Global
Last Price:
36.40
Seasonality Move:
4.66%
Sell
46
ProShares Ultra Nasdaq Biotechnology (BIB)
is a Sell
Is ProShares Ultra Nasdaq Biotechnology a Buy, Sell or Hold?
- The current ProShares Ultra Nasdaq Biotechnology [BIB] share price is $59.53. The Score for BIB is 46, which is 8% below its historic median score of 50, and infers higher risk than normal.
- BIB is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
62
Fundamental Global (FGF)
is a Buy
Is Fundamental Global a Buy, Sell or Hold?
- The current Fundamental Global [FGF] share price is $37.70. The Score for FGF is 62, which is 24% above its historic median score of 50, and infers lower risk than normal.
- FGF is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
BIB Stock Price Chart
What is ProShares Ultra Nasdaq Biotechnology's stock price today?
-
The ProShares Ultra Nasdaq Biotechnology share price today is $59.53
The current trend is relatively stagnant and BIB is experiencing selling pressure, which indicates risk of future bearish movement.
FGF Stock Price Chart
What is Fundamental Global's stock price today?
-
The Fundamental Global share price today is $37.70
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and FGF is experiencing buying pressure, which is a positive indicator for future bullish movement.
BIB Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -1.32 | Sell |
| Relative Strength Index (14 RSI): | 48.99 | Sell |
| Chaikin Money Flow: | -4483 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (56.31 - 64.21) | Sell |
| Bollinger Bands (100): | (60.15 - 66.99) | Sell |
FGF Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 7.09 | Buy |
| Relative Strength Index (14 RSI): | 69.71 | Buy |
| Chaikin Money Flow: | 11009 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (10.46 - 32.92) | Buy |
| Bollinger Bands (100): | (-4.42 - 16.74) | Buy |
BIB Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 56.98 | Buy |
| 20-day SMA: | 59.83 | Sell |
| 50-day SMA: | 61.75 | Sell |
| 200-day SMA: | 59.97 | Sell |
| 8-day EMA: | 58.25 | Buy |
| 20-day EMA: | 59.21 | Buy |
| 50-day EMA: | 61.12 | Sell |
| 200-day EMA: | 60.1 | Sell |
FGF Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 32.62 | Buy |
| 20-day SMA: | 25.6 | Buy |
| 50-day SMA: | 11.33 | Buy |
| 200-day SMA: | 3.71 | Buy |
| 8-day EMA: | 32.27 | Buy |
| 20-day EMA: | 25.69 | Buy |
| 50-day EMA: | 15.82 | Buy |
| 200-day EMA: | 5.86 | Buy |
ProShares Ultra Nasdaq Biotechnology Earnings Growth & BIB Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Fundamental Global Earnings Growth & FGF Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
ProShares Ultra Nasdaq Biotechnology Technical Analysis
| Nov 15 | Nov 18 | Nov 19 | Nov 20 | Nov 21 | Nov 22 | Nov 25 | Nov 26 | Nov 27 | Nov 29 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 15 | 18 | 19 | 20 | 21 | 22 | 25 | 26 | 27 | 29 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Fundamental Global Technical Analysis
| Nov 15 | Nov 18 | Nov 19 | Nov 20 | Nov 21 | Nov 22 | Nov 25 | Nov 26 | Nov 27 | Nov 29 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 15 | 18 | 19 | 20 | 21 | 22 | 25 | 26 | 27 | 29 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||